Literature DB >> 11166376

Down-regulation of Pim-1 and Bcl-2 is accompanied with apoptosis of interleukin-6-depleted mouse B-cell hybridoma 7TD1 cells.

Z Rahman1, H Yoshikawa, Y Nakajima, K Tasaka.   

Abstract

Here we report, interleukin-6 (IL-6) dependent mouse B-cell hybridoma, 7TD1 cells underwent apoptotic cell death with the starvation of IL-6. First, 7TD1 cells cultured without IL-6 arrested at G0/G1 phase (maximum accumulation at 24 h ) of the cell cycle. After that, the parameters of apoptosis namely, decreased mitochondrial transmembrane potential (DeltaPsi(m)), activation of caspases, DNA fragmentation and morphological changes (condensed nucleus and formation of apoptotic bodies) were observed. As evidents by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analyses, down-regulation of Pim-1 (a serine/threonine kinase) and Bcl-2 was observed in the IL-6-depleted 7TD1 cells. There was no change in the expression of c-Myc, Bcl-xL and Mcl-1, even at 48 h of IL-6-depletion. Taken together, these results indicate that IL-6 withdrawn from the 7TD1 cells resulted in G0/G1 arrest and then caspase-dependent apoptosis via mitochondrial pathway by down-regulation of Pim-1 and Bcl-2, which may be essential for anti-apoptotic signals of IL-6.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166376     DOI: 10.1016/s0165-2478(00)00322-9

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation.

Authors:  Anissa M Jabbour; Carmel P Daunt; Benjamin D Green; Sandra Vogel; Lavinia Gordon; Rachel S Lee; Natasha Silke; Richard B Pearson; Cassandra J Vandenberg; Priscilla N Kelly; Stephen L Nutt; Andreas Strasser; Christoph Borner; Paul G Ekert
Journal:  Blood       Date:  2009-11-17       Impact factor: 22.113

Review 2.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

3.  Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats.

Authors:  Kenichiro Yata; Gerald A Matchett; Tamiji Tsubokawa; Jiping Tang; Kenji Kanamaru; John H Zhang
Journal:  Brain Res       Date:  2007-02-17       Impact factor: 3.252

Review 4.  PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer.

Authors:  Sutapa Mahata; Pranab K Sahoo; Ranita Pal; Sinjini Sarkar; Tanuma Mistry; Sushmita Ghosh; Vilas D Nasare
Journal:  Med Oncol       Date:  2022-05-15       Impact factor: 3.064

5.  Salivary glands of primary Sjögren's syndrome patients express factors vital for plasma cell survival.

Authors:  Ewa A Szyszko; Karl A Brokstad; Gunnvor Oijordsbakken; Malin V Jonsson; Roland Jonsson; Kathrine Skarstein
Journal:  Arthritis Res Ther       Date:  2011-01-07       Impact factor: 5.156

6.  JunD/AP-1-mediated gene expression promotes lymphocyte growth dependent on interleukin-7 signal transduction.

Authors:  Shannon M Ruppert; Mounir Chehtane; Ge Zhang; Haiyan Hu; Xiaoman Li; Annette R Khaled
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

7.  PI3-K/Akt pathway contributes to IL-6-dependent growth of 7TD1 cells.

Authors:  JiYan Zhang; Yan Li; BeiFen Shen
Journal:  Cancer Cell Int       Date:  2003-02-17       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.